Original language | English |
---|---|
Pages (from-to) | 620-621 |
Number of pages | 2 |
Journal | Journal of Hepatology |
Volume | 68 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2018 |
Reply to: “Predictors of sorafenib benefit in patients with hepatocellular carcinoma”
Jordi Bruix, Ann Lii Cheng, Josep Llovet
Research output: Contribution to journal › Letter › peer-review
1
Scopus
citations